[Therapy of peptic ulcer and chronic pancreatitis].
Medical treatment of gastric and duodenal ulcerations has recently been improved and extended by anti-aggressive and protectively acting drugs (e.g., H2-receptor antagonists and carbenoxolone sodium). However, antacids and anticholinergic treatment are still being used in modern ulcer management. The most important therapeutical measures against  chronic relapsing pancreatitis are abstinence from ethanol and surgical treatment of biliary or pancreatic duct obstructions. Symptomatic management--pancreatic enzyme substitution and analgetics, antacids, anticholinergics--is adequate in pancreatic insufficiency and during acute exacerbation, respectively.
D000863:Antacids / Q000627:therapeutic use; D002229:Carbenoxolone / Q000627:therapeutic use; D002908:Chronic Disease; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010195:Pancreatitis / Q000175:diagnosis / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D010276:Parasympatholytics / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*
D000863:Antacids; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D002229:Carbenoxolone
Zur Therapie des peptischen Ulkus und der chronischen Pankreatitis